FDA Proposed Rule Addresses “Demonstrably Difficult” Compounded Drugs/Categories

An FDA proposed rule will establish criteria the agency will use to create two lists — drug products and categories of drug products — that present demonstrable difficulties for compounding (DDC Lists) and identify three categories of drug products on both DDC Lists.
Source: Drug Industry Daily